NCT07099131

Brief Summary

The purpose of this study is to evaluate the use of various techniques in alleviating gag reflex following gag reflex stimulation. Primary aim: To compare if there is any reduction in gag reflex from each of the following interventions

  • Acupuncture (CV-24)
  • Tape
  • Anesthetic spray Secondary aim: to compare the degree of gag reduction

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P50-P75 for early_phase_1

Timeline
32mo left

Started Dec 2025

Typical duration for early_phase_1

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress14%
Dec 2025Dec 2028

First Submitted

Initial submission to the registry

July 8, 2025

Completed
24 days until next milestone

First Posted

Study publicly available on registry

August 1, 2025

Completed
4 months until next milestone

Study Start

First participant enrolled

December 7, 2025

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 7, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 7, 2028

Last Updated

August 1, 2025

Status Verified

July 1, 2025

Enrollment Period

2 years

First QC Date

July 8, 2025

Last Update Submit

July 24, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Gag Reflex Severity Index (GSI) Score From Pre- to Post-Intervention

    Change in Gag Reflex Severity Index (GSI) Score From Baseline to Post-Intervention * Acupuncture (CV-24) * Tape * Anesthetic spray Gag reflex severity will be assessed by clinicians using the Gagging Severity Index (GSI), based on definitions set by Dickinson and Fiske. GSI will first be recorded after initial gag stimulation with a cotton swab. Following randomization to one of three interventions (acupuncture, anesthetic spray, or masking tape), GSI will be recorded again. The change in GSI score will be used to measure change in gag response.

    90 minutes per subject

Secondary Outcomes (1)

  • Self-Reported Degree of Gag Reflex Reduction Using Visual Analog Scale (VAS)

    Immediately post-intervention during single study visit

Study Arms (3)

Acupuncture (CV-24)

EXPERIMENTAL

A 6C file (endodontic instrumentation file) will be placed on the patient's mentolabial fold (CV24). This file will be concealed by a small paper cup; A clean alcohol wipe will be used to clean the mentolabial area prior to placing the "acupuncture needle" (6 C-File).

Device: Acupuncture

Tape

EXPERIMENTAL

A piece of commercially available masking tape will be adhered to the patient's mentolabial fold and concealed by the small paper cup

Genetic: Masking Tape

Anesthetic spray

EXPERIMENTAL

Will be applied to back of the throat for 10 seconds; their chin will also be concealed from the GSI examiner using a small cup and masking tape.

Drug: Anesthetic spray

Interventions

will be applied to back of the throat for 10 seconds; their chin will also be concealed from the GSI examiner using a small cup and masking tape.

Anesthetic spray

A 6C file (endodontic instrumentation file) will be placed on the patient's mentolabial fold (CV24). This file will be concealed by a small paper cup; A clean alcohol wipe will be used to clean the mentolabial area prior to placing the "acupuncture needle" (6 C-File).

Acupuncture (CV-24)

A piece of commercially available masking tape will be adhered to the patient's mentolabial fold and concealed by the small paper cup

Tape

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years or older (individuals below 18 years will be excluded from the study as the study procedures might not be well tolerated by them, and they are not the primary population on which these procedures are used).
  • Students, faculty, or staff of Tufts SDM
  • Subjects who score a 2 or higher on the Gagging Severity Index (GSI)7 and have a positive gag reflex response when stimulated with a cotton swab at the base of the tongue/uvula/tonsil region.

You may not qualify if:

  • Adults unable to consent (cognitively impaired adults)
  • Wards of the state
  • Pregnant women (those that are self-reported)
  • Current use of anticoagulants
  • Allergy to xylocaine
  • Those with bleeding disorders
  • Those who participated in the Calibration phase of this study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tufts University School of Dental Medicine

Boston, Massachusetts, 02111, United States

Location

MeSH Terms

Conditions

Gagging

Interventions

Acupuncture Therapy

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Study Officials

  • Devon Ptak

    Tufts University School of Dental Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Unblinded. Subjects will be randomized. The three intervention groups are : Acupuncture (CV-24), Tape and Anesthetic Spray.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 8, 2025

First Posted

August 1, 2025

Study Start

December 7, 2025

Primary Completion (Estimated)

December 7, 2027

Study Completion (Estimated)

December 7, 2028

Last Updated

August 1, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations